
Bob More
QuietNamed in filings at Alta Partners
- Board seats filed
- 11
all filings on record

Named in filings at Alta Partners
all filings on record
last 24 months
from a verified or cited source
| Tyra Biosciences | Biotech & pharma | February 2024 | None on file |
| Kelonia Therapeutics | Biotech & pharma | April 2022 | Venrock |
| Hunger Not Impossible | Food & agriculture | August 2020 | HealthX Ventures |
| Variant Bio | Biotech & pharma | July 2020 | Dimension Capital, Lux Capital |
| eGenesis | Biotech & pharma | November 2019 | Aditum Bio, ARCH Venture Partners |
| Ally Therapeutics | Biotech & pharma | July 2019 | ARCH Venture Partners |
| Vir Biotechnology | Biotech & pharma | June 2018 | ARCH Venture Partners |
| Affinivax | Biotech & pharma | December 2017 | Bain Capital Life Sciences |
| Sienna Labs | Biotech & pharma | October 2015 | None on file |
| Cartiva | Biotech & pharma | April 2015 | None on file |
| Carticept Medical | Medical devices | December 2011 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The category is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Categories of companies where filings name Bob More on the board, based on 11 filed seats with a verified or cited source.